ClinConnect ClinConnect Logo
Search / Trial NCT06874439

An Evaluation of the WHO QUAlityRights Program

Launched by GCS-CCOMS · Mar 7, 2025

Trial Information

Current as of April 22, 2025

Active, not recruiting

Keywords

User Rights Recovery Oriented Practices Mental Health Settings Satisfaction With Care Interventional Study Randomized Controlled Trial

ClinConnect Summary

In France, despite the existence of recommendations and a restrictive legal framework, the use of restraint practices in psychiatry remains widespread, and the duration and conditions of hospitalization do not always guarantee respect for users' rights.

The World Health Organization's (WHO) QualityRights (QR) program offers assessments, called "observations", and recommendations to help mental health facilities, on a voluntary basis, improve their care practices towards better respect of the rights of service users. However, the program has never been evaluated in a French national context...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults (18 years or older)
  • Persons having formulated a non-opposition to participate in the study
  • Population a (users): Service users of the psychiatric sectors involved in the study hospitalized full-time since at least 3 days in an inpatient unit.
  • Population b (professionals): Mental health professionals working in the sector since at least 3 months at the time of study participation
  • Exclusion Criteria:
  • Persons physically or psychologically unable to participate at the time of the study
  • Persons subject to a safeguard of justice measure
  • Persons who do not speak or understand the French language

Trial Officials

Déborah Sebbane, MD, PhD

Study Chair

GCS-CCOMS & ECEVE 1123 INSERM

About Gcs Ccoms

GCS-CCOMS is a leading clinical trial sponsor dedicated to advancing innovative therapies through rigorous research and development. With a strong commitment to enhancing patient outcomes, the organization specializes in the design, implementation, and management of clinical trials across various therapeutic areas. GCS-CCOMS collaborates with academic institutions, healthcare providers, and pharmaceutical companies to ensure the highest standards of scientific integrity and regulatory compliance. Through a patient-centered approach and a focus on ethical practices, GCS-CCOMS strives to contribute to the advancement of medical knowledge and improve the quality of care available to patients worldwide.

Locations

Armentières, , France

Armentières, , France

Erstein, , France

Laxou, , France

Montéléger, , France

Nanterre, , France

Nice, , France

Plaisir, , France

Plaisir, , France

Pont Du Casse, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported